
Efta T 250mg/31.25mg Injection
Marketer
H & Care Incorp
Salt Composition
Ceftazidime (250mg) + Tazobactum (31.25mg)
Overview Efta T 250mg/31.25mg Injection
Combiflox Injection (250mg/31.25mg) is a dual-action antibiotic used to combat diverse bacterial infections. Its mechanism inhibits microbial proliferation, thereby curbing infection spread. Administration must always be overseen by a qualified medical professional. Consistent adherence to the prescribed dosage schedule is crucial; completing the entire course is essential, even with symptom improvement. Premature cessation can compromise its effectiveness. Commonly reported side effects include nausea, vomiting, diarrhea, and dyspepsia. Any worsening of side effects warrants immediate medical consultation. Allergic reactions (e.g., rash, pruritus, edema, dyspnea) require prompt medical attention. Prior to commencing treatment, inform your physician of all current medications and pre-existing health conditions. Pregnant or lactating individuals should seek medical advice before use. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, a balanced diet, and sufficient hydration contribute to faster recovery. Your physician may order laboratory tests to monitor treatment efficacy.
Uses of Efta T 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Efta T 250mg/31.25mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Efta T 250mg/31.25mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Stomach pain
- Increased liver enzymes
- Allergic reaction
How to use Efta T 250mg/31.25mg Injection:
Administering this medication will be performed by your physician or their qualified assistant; self-medication is strictly prohibited.
How Efta T 250mg/31.25mg Injection works:
Ceftazidime/Tazobactam injection (Efta T 250mg/31.25mg) unites two drugs to combat bacterial infection. Ceftazidime, an antibiotic, disrupts bacterial cell wall synthesis, hindering their survival. Tazobactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thus boosting Ceftazidime's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Efta T 250mg/31.25mg Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
Administration of Efta T 250mg/31.25mg Injection is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; yet, clinical data in humans are scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication, Efta T 250mg/31.25mg, presents no known breastfeeding contraindications. Research in humans indicates minimal drug transfer to breast milk, posing no identified risk to the infant.
DrivingUNSAFE
Administering Efta T 250mg/31.25mg Injection can lead to drowsiness, blurred vision, and dizziness. Refrain from operating a vehicle if these side effects manifest.
KidneyCAUTION
Renal impairment necessitates careful administration of Efta T 250mg/31.25mg Injection. Dosage modification may be required. Physician consultation is advised.
LiverCAUTION
The injectable medication, Efta T 250mg/31.25mg, requires careful administration to individuals with advanced hepatic impairment. Dosage modification for Efta T 250mg/31.25mg Injection may be necessary. Physician consultation is advised.
What if you forget to take Efta T 250mg/31.25mg Injection :
Should you forget a scheduled dose of Efta T 250mg/31.25mg Injection, seek advice from your physician.
Facts to Know About Efta T 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Antimicrobials |
